Compounds > ellipticine

ellipticine and 9-methoxyellipticine

ellipticine has been researched along with 9-methoxyellipticine in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (25.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	3 (37.50)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borgna, JL; Delbarre, A; Jacquemin-Sablon, A; Le Pecq, JB; Oberlin, R; Rochefort, H; Roques, BP	1
Auclair, C; Paoletti, C	1
Acton, EM; Boyd, MR; Narayanan, VL; Risbood, PA; Shoemaker, RH; Vistica, DT	1
Auclair, C; Dubreuil, P; Le Bret, M; Letard, S; Martin, F; Svinarchuk, F; Vendôme, J	1
Addepalli, R; Carroll, AR; Fechner, G; Forster, PI; Guymer, GP; Quinn, RJ; Smith, J	1
Amorim, RC; Costa, DS; Costa, MR; Eberlin, MN; Grafov, A; Grafova, I; Henrique, MC; Lima, ES; Montoia, A; Pohlit, AM; Rocha E Silva, LF; Souza, RC; Tadei, WP; Torres, ZE; Vasconcellos, MC	1
Craik, DJ; Garson, MJ; Salim, AA	1
Huang, ZS; Li, W; Rao, Y; Xu, YH; Yin, S	1

Other Studies

8 other study(ies) available for ellipticine and 9-methoxyellipticine

Article	Year
Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer. Journal of medicinal chemistry, 1985, Volume: 28, Issue:6 Topics: Alkaloids; Animals; Breast Neoplasms; Cattle; Cell Line; DNA; Ellipticines; Female; Humans; In Vitro Techniques; Intercalating Agents; Leukemia L1210; Neoplasms, Hormone-Dependent; Receptors, Estrogen	1985
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system. Journal of medicinal chemistry, 1981, Volume: 24, Issue:3 Topics: Alkaloids; Animals; Antineoplastic Agents; Biotransformation; Ellipticines; Hydrogen Peroxide; Mice; Oxidation-Reduction; Peroxidases; Structure-Activity Relationship	1981
Anticancer specificity of some ellipticinium salts against human brain tumors in vitro. Journal of medicinal chemistry, 1994, Jul-08, Volume: 37, Issue:14 Topics: Brain Neoplasms; Drug Evaluation, Preclinical; Ellipticines; Humans; Structure-Activity Relationship; Tumor Cells, Cultured	1994
Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases. Journal of medicinal chemistry, 2005, Oct-06, Volume: 48, Issue:20 Topics: Adenosine Triphosphate; Binding, Competitive; Ellipticines; Mutation; Protein Conformation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit	2005
Alkaloids from the Australian rainforest tree Ochrosia moorei. Journal of natural products, 2008, Volume: 71, Issue:6 Topics: Alkaloids; Australia; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Ochrosia; Plant Leaves; Plant Stems; Trees	2008
Antiplasmodial activity of synthetic ellipticine derivatives and an isolated analog. Bioorganic & medicinal chemistry letters, 2014, Jun-15, Volume: 24, Issue:12 Topics: Animals; Antimalarials; Aspidosperma; Chloroquine; Disease Models, Animal; Ellipticines; Fibroblasts; Humans; Mice; Molecular Structure; Plant Bark; Plasmodium falciparum	2014
New indole alkaloids from the roots of Ochrosia acuminata. Journal of natural products, 2004, Volume: 67, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Ellipticines; Indole Alkaloids; Indonesia; Mass Spectrometry; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Ochrosia; Plant Roots; Plants, Medicinal	2004
Pyridocarbazole alkaloids from Ochrosia borbonica: lipid-lowering agents inhibit the cell proliferation and adipogenesis of 3T3-L1 adipocyte via intercalating into supercoiled DNA. Chinese journal of natural medicines, 2019, Volume: 17, Issue:9 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Carbazoles; Cell Proliferation; DNA Damage; DNA, Superhelical; Ellipticines; Hypolipidemic Agents; Lipid Metabolism; Mice; Molecular Structure; Ochrosia; Plant Extracts; Topoisomerase Inhibitors	2019